Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)

PHASE3CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Asthma
Interventions
DRUG

salmeterol

50 micrograms (mcg) twice per day (BID) (Serevent 50 mcg diskus, GlaxoSmithKline (GSK), North Carolina)

DRUG

beclomethasone HFA

240 mcg beclomethasone HFA (QVAR, Teva Pharmaceutical Industries)

Trial Locations (7)

27103

Wake Forest University Health Sciences, Winston-Salem

63110

Washington University, St Louis

80206

National Jewish Medical & Research Center, Denver

92103

University of California, San Diego, San Diego

94143-0130

University of California, San Francisco, San Francisco

02115

Brigham & Women's Hospital, Boston

53792-3244

University of Wisconsin Madison, Madison

Sponsors
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Asthma Clinical Research Network

NETWORK

lead

Milton S. Hershey Medical Center

OTHER